Literature DB >> 15016448

Ontogenic and adult whole body distribution of aminopeptidase N in rat investigated by in vitro autoradiography.

Fanny Jardinaud1, Ghasal Banisadr, Florence Noble, Stéphane Mélik-Parsadaniantz, Huixiong Chen, Christophe Dugave, Hervé Laplace, William Rostène, Marie-Claude Fournié-Zaluski, Bernard P Roques, Théodora Popovici.   

Abstract

Aminopeptidase N (APN), which is widely distributed in mammalian tissues, is able to cleave numerous regulatory peptides. The selective inhibitor of APN, [(125)I] RB129, has been used to study the distribution of this exopeptidase during rat prenatal development and adult life by in vitro whole-body autoradiography. In the central nervous system, APN shows a weak labeling compared to the major part of the non-nervous tissues in the embryo and in the adult. APN is progressively expressed in kidney, intestine, heart, lung, sensory organs, eye, and thymus. In organs such as the liver, the cartilages and the bones, altered levels of APN expression are observed during the development, or in the embryo compared to the adult, suggesting a role of APN during the liver haematopoiesis and bone growth. At this time, all the physiological functions of APN are still incompletely known, however its developmental pattern of expression strongly suggests a function of modulation of this enzyme during the development, next in physiological and/or pathological situations in adult. In this way, APN could represent a new therapeutic target in pathological processes, such as tumoral proliferation and/or angiogenesis associated with cancer development, where an increase in the level of this enzyme has been observed.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15016448     DOI: 10.1016/j.biochi.2003.12.004

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  6 in total

Review 1.  Inhibiting the breakdown of endogenous opioids and cannabinoids to alleviate pain.

Authors:  Bernard P Roques; Marie-Claude Fournié-Zaluski; Michel Wurm
Journal:  Nat Rev Drug Discov       Date:  2012-04       Impact factor: 84.694

Review 2.  Involvement of insulin-regulated aminopeptidase in the effects of the renin-angiotensin fragment angiotensin IV: a review.

Authors:  Bart Stragier; Dimitri De Bundel; Sophie Sarre; Ilse Smolders; Georges Vauquelin; Alain Dupont; Yvette Michotte; Patrick Vanderheyden
Journal:  Heart Fail Rev       Date:  2007-11-08       Impact factor: 4.214

3.  Evaluation of (99m)Tc-probestin SPECT as a novel technique for noninvasive imaging of kidney aminopeptidase N expression.

Authors:  Gopal Pathuri; Venkateshwar Madka; Andria F Hedrick; Stanley A Lightfoot; Vibhudutta Awasthi; Benjamin D Cowley; Chinthalapally V Rao; Hariprasad Gali
Journal:  Mol Pharm       Date:  2014-07-10       Impact factor: 4.939

Review 4.  Aminopeptidase-N/CD13 (EC 3.4.11.2) inhibitors: chemistry, biological evaluations, and therapeutic prospects.

Authors:  Brigitte Bauvois; Daniel Dauzonne
Journal:  Med Res Rev       Date:  2006-01       Impact factor: 12.944

5.  Wheat oligopeptides enhance the intestinal mucosal barrier and alleviate inflammation via the TLR4/Myd88/MAPK signaling pathway in aged mice.

Authors:  Yang Xian; Pan Da; Yang Chao; Xia Hui; Yang Ligang; Wang Shaokang; Sun Guiju
Journal:  Food Nutr Res       Date:  2022-02-14       Impact factor: 3.894

Review 6.  Cisplatin chemotherapy and renal function.

Authors:  Jie Zhang; Zhi-Wei Ye; Kenneth D Tew; Danyelle M Townsend
Journal:  Adv Cancer Res       Date:  2021-04-28       Impact factor: 6.242

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.